PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC announced today the appointment of Dr. Susan Langer as Chief Medical Officer and Vice President of Research & Development effective June 4, 2007 reporting to Iroko President and CEO John Vavricka. In addition, the company announced the appointment of additional members of its executive team. “We are thrilled to welcome highly skilled seasoned professionals with significant industry experience to our executive team,” said John Vavricka. “In addition, our Chief Medical officer brings a broad range of experience in clinical research and development which will enable Iroko to maximize life cycle development through new formulations and indications.”
